Expiring federal contract · order under a contract vehicle
75A50124F61009 — Seqirus INC
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Contract / PIID
- 75A50124F61009
- Incumbent
- Seqirus INC
- Incumbent UEI
- Z6N1LJ2RD6E3
- Current end date
- May 21, 2027
- Potential total value
- $396,030
- Obligated
- $396,030
- NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- February 22, 2024
- Place of performance
- NC
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
This is an order under contract vehicle 75A50122D00004. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325414)
- 75A50125C00002 — Sanofi Vaccines US INC. · ends January 31, 2027 · $53M
- 75A50124F61004 — Advanced Technology International · ends April 11, 2027 · $51M
- 75A50126F61013 — Seqirus INC · ends May 8, 2027 · $450K
- 75N93023P00594 — Dna Twopointo INC. · ends May 13, 2027 · $300K
- 75N98026P00545 — Somalogic Operating CO., INC · ends May 14, 2027 · $522K
- 75A50124F61008 — Seqirus INC · ends May 21, 2027 · $23M
- 75N98026P00626 — Olink Proteomics INC · ends May 28, 2027 · $207K
- 75N98026P00928 — Pacific Biosciences Of California, INC · ends July 7, 2027 · $347K
- 75N98026P01001 — Life Technologies Corporation · ends August 6, 2027 · $110K
- 75N98026F00001 — Roche Diagnostics Corporation · ends August 31, 2027 · $127K